|
TTLL11 expression based on
|
| Comparison | Statistical significance |
| Normal-vs-Primary | 1.62481139653892E-12 |
|
Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
6.16173778666962E-14 |
| Normal-vs-Stage2 |
5.96549999999363E-05 |
| Normal-vs-Stage3 |
7.7715611723761E-16 |
| Normal-vs-Stage4 |
1.63935531816151E-12 |
| Stage1-vs-Stage2 |
1.128630E-01 |
| Stage1-vs-Stage3 |
4.491900E-02 |
| Stage1-vs-Stage4 |
2.259800E-03 |
| Stage2-vs-Stage3 |
1.376280E-02 |
| Stage2-vs-Stage4 |
8.973600E-04 |
| Stage3-vs-Stage4 |
1.295150E-01 |
|
|
Note
Patient race information is not available for 92 samples and one samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
3.33066907387547E-16 |
| Normal-vs-AfricanAmerican |
2.63400000000136E-06 |
| Normal-vs-Asian |
3.67209995744133E-09 |
| Caucasian-vs-AfricanAmerican |
6.918400E-01 |
| Caucasian-vs-Asian |
6.084000E-01 |
| AfricanAmerican-vs-Asian |
9.869800E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
8.32667268468867E-15 |
| Normal-vs-Female |
1.62803104331033E-12 |
| Male-vs-Female |
2.045200E-01 |
|
|
Note
Seventeen samples from patient below 21 years not considered in above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
1.8810508706224E-12 |
| Normal-vs-Age(41-60Yrs) |
2.72004641033163E-14 |
| Normal-vs-Age(61-80Yrs) |
8.35109759123043E-12 |
| Normal-vs-Age(81-100Yrs) |
4.41780000000058E-05 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
4.719400E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
2.558600E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
2.870000E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
5.828200E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
4.288600E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
5.972000E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Classical-VS-Tall |
2.46640000000076E-05 |
| Classical-VS-Follicular |
8.807000E-01 |
| Classical-VS-Other |
4.378200E-01 |
| Classical-VS-Normal |
1.64090963039598E-12 |
| Tall-VS-Follicular |
4.582100E-04 |
| Tall-VS-Other |
2.890200E-01 |
| Tall-VS-Normal |
8.88178419700125E-16 |
| Follicular-VS-Other |
4.747200E-01 |
| Follicular-VS-Normal |
4.48049997103794E-09 |
| Other-VS-Normal |
4.046100E-04 |
|
|
Note
Cancer in nearby lymph nodes cannot be measured (NX) in 50 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
2.1268986571954E-11 |
| Normal-vs-N1 |
1.64301905414277E-12 |
| N0-vs-N1 |
2.308000E-02 |
|
|
